Menu
04/09/2006
Vaccine could reduce cervical cancer deaths
A new vaccine could help reduce deaths from cervical cancer in the UK by 75%, a study has found.
The study examined the effect of the Cervarix vaccine, developed by GlaxoSmithKline.
Cervarix targets two of the most common strains of the human papilllomavirus (HPV), which is responsible for around 70% if all cervical cancers. In the study, a computer model was used to predict the outcome of using the vaccine on all 12-year-old girls in the UK.
The researchers accepted that 100% use of the vaccine was unrealistic, but said that even if 60% were vaccinated, the number of deaths from cervical cancer would be reduced.
Cervarix, which is still in development and would not be eligible European approval for around another year, would be in competition with Gardasil, a vaccine developed by Sanofi Pasteur.
Gardasil has been granted a European license and could be available in the UK within months.
Commenting on the latest news, Dr Anne Szarewski, clinical consultant at Cancer Research UK said: "The idea of finally being able to prevent cases of cervical cancer with a vaccine is extremely exciting."
(KMcA/SP)
The study examined the effect of the Cervarix vaccine, developed by GlaxoSmithKline.
Cervarix targets two of the most common strains of the human papilllomavirus (HPV), which is responsible for around 70% if all cervical cancers. In the study, a computer model was used to predict the outcome of using the vaccine on all 12-year-old girls in the UK.
The researchers accepted that 100% use of the vaccine was unrealistic, but said that even if 60% were vaccinated, the number of deaths from cervical cancer would be reduced.
Cervarix, which is still in development and would not be eligible European approval for around another year, would be in competition with Gardasil, a vaccine developed by Sanofi Pasteur.
Gardasil has been granted a European license and could be available in the UK within months.
Commenting on the latest news, Dr Anne Szarewski, clinical consultant at Cancer Research UK said: "The idea of finally being able to prevent cases of cervical cancer with a vaccine is extremely exciting."
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
04 April 2003
Cervical cancer risk link to contraceptive pill
Women who take the contraceptive pill may increase their risk of cervical cancer, according to a major new study published in the Lancet today.
Cervical cancer risk link to contraceptive pill
Women who take the contraceptive pill may increase their risk of cervical cancer, according to a major new study published in the Lancet today.
05 December 2003
New 'more effective' cervical cancer test developed
A new test has been developed that could provide a "more effective early warning system" for preventing cervical cancer than the traditional smear – according to Cancer Research UK scientists.
New 'more effective' cervical cancer test developed
A new test has been developed that could provide a "more effective early warning system" for preventing cervical cancer than the traditional smear – according to Cancer Research UK scientists.
02 July 2003
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
04 February 2014
Cervical Cancer Vaccine Could Be 'Hugely Beneficial' To Boys
A vaccination that protects girls from cervical cancer could be used to save thousands of boys lives in Britain. The jab, which immunises 12 and 13-year-old girls against Human Papilloma Virus (HPV), would be "hugely beneficial" to boys as well, according to campaigners.
Cervical Cancer Vaccine Could Be 'Hugely Beneficial' To Boys
A vaccination that protects girls from cervical cancer could be used to save thousands of boys lives in Britain. The jab, which immunises 12 and 13-year-old girls against Human Papilloma Virus (HPV), would be "hugely beneficial" to boys as well, according to campaigners.
18 July 2012
Schools Denying Cervical Cancer Vaccine On Religious Grounds
Schoolgirls are being denied a potentially life-saving cervical cancer jab at their schools on religious grounds. The jab guards against two strains of the human papillomavirus (HPV) virus – 16 and 18 – which cause 70% of cases of cervical cancer. It is offered routinely to girls aged 12 to 13.
Schools Denying Cervical Cancer Vaccine On Religious Grounds
Schoolgirls are being denied a potentially life-saving cervical cancer jab at their schools on religious grounds. The jab guards against two strains of the human papillomavirus (HPV) virus – 16 and 18 – which cause 70% of cases of cervical cancer. It is offered routinely to girls aged 12 to 13.
-
Northern Ireland WeatherThis Evening and Tonight:It will be cloudy with a spell of heavy rain pushing south through late evening and the early hours, soon followed by some clear spells. Minimum temperature 6 °C.
